# Open Label Phase IIa Trial Evaluating the Effect and Safety of Transplantation of Fecal Microbiota in Children With Autism Spectrum Disorders and Gastrointestinal Symptoms

> **NCT07105267** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 5 (estimated)

## Conditions studied

- Autism Spectrum Disorder
- Fecal Microbiota Transplantation (FMT)

## Interventions

- **DRUG:** FMT Protocol

## Key facts

- **NCT ID:** NCT07105267
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2025-08-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07105267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07105267, "Open Label Phase IIa Trial Evaluating the Effect and Safety of Transplantation of Fecal Microbiota in Children With Autism Spectrum Disorders and Gastrointestinal Symptoms". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07105267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*